Protective role of edaravone against neomycin-induced ototoxicity in zebrafish

Research output: Contribution to journalArticle

13 Citations (Scopus)


Aminoglycosides such as neomycin are one of the most commonly prescribed types of antibiotics worldwide. However, these drugs appear to generate free radicals within the inner ear, which can result in permanent hearing loss. We evaluated the effects of edaravone, a neuroprotective agent, on neomycin-induced ototoxicity in transgenic zebrafish. The 5-day post fertilization (dpf) zebrafish larvae were exposed to 125μM neomycin and various concentrations of edaravone for 1h. Hair cell survival was calculated as average numbers of the hair cells in the control group, which was not exposed to neomycin. Ultrastructural changes were evaluated using a scanning electron microscope (SEM) and transmission electron microscope (TEM). Edaravone protected against neomycin-induced hair cell loss in the neuromasts (1000μM: 11.6±1.1 cells, neomycin only: 5.5±0.5 cells; n=10, P<0.05) and decreased the TUNEL reaction for detecting apoptosis. In ultrastructural analysis, structures of mitochondria and hair cells within neuromasts were preserved in zebrafish exposed to 125μM neomycin and 1000μM edaravone for 1h. Edaravone protected against neomycin-induced hair cell loss by preventing apoptosis.

Original languageEnglish
Pages (from-to)554-561
Number of pages8
JournalJournal of Applied Toxicology
Issue number5
Publication statusPublished - 2014 May



  • Edaravone
  • Hearing
  • Neomycin
  • Ototoxicity
  • Zebrafish

ASJC Scopus subject areas

  • Toxicology

Cite this